Interference of proteins involved in the cytoplasmic sequestration of p53 with human papillomavirus EG-mediated degradation

被引:0
|
作者
Isaacs, JS
Barrett, JC
Weissman, BE
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] NIEHS, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA
关键词
p53; human papillomavirus E6; stability; sequestration; neuroblastoma;
D O I
10.1002/(SICI)1098-2744(199901)24:1<70::AID-MC10>3.0.CO;2-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The oncogenic human papillomaviruses (HPVs) are able to efficiently target p53 for degradation by the ubiquitin pathway. We previously demonstrated inefficient HPV EG-mediated degradation and resulting high steady-state levels of p53 in cell hybrids between a peripheral neuroepithelioma cell line and a cervical carcinoma cell line (HeLa). We now show that the p53 protein in these cell hybrids was cytoplasmically sequestered and exhibited sporadic punctate staining, which is characteristic of the p53 expression pattern observed in neuroblastic neuroblastoma (NB) cell lines, in which p53 is also sequestered. We hypothesized that the cytoplasmic sequestration of p53 in the cell hybrids might correlate with its inability to be rapidly degraded by I-IPV E6. Using NE cell lines as a model system to test this hypothesis, we demonstrated that the introduction of HPV E6 into two NE cell lines resulted in p53 insensitivity to HPV E6-mediated degradation. This was assessed by both pulse-chase analysis of p53 in metabolically labeled NE cells and western blotting. The enhanced stability of p53 was not due to a lack of HPV E6 expression or to a mutant conformation of the p53 protein. Our results therefore suggest that proteins involved in the cytoplasmic sequestration of p53 may also interfere with the ability of HPV E6 to target p53 for degradation. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:70 / 77
页数:8
相关论文
共 50 条
  • [31] Human papillomavirus DNA and p53 status in penile carcinomas
    Levi, JE
    Rahal, P
    Sarkis, AS
    Villa, LL
    INTERNATIONAL JOURNAL OF CANCER, 1998, 76 (06) : 779 - 783
  • [32] Human papillomavirus infection and alterations of p53 in esophageal cancer
    Ogoshi, S
    Ishikawa, T
    Furihata, M
    Takahashi, A
    Inoue, A
    Ono, H
    Murakami, H
    Ohtsuki, Y
    RECENT ADVANCES IN GASTROENTEROLOGICAL CARCINOGENESIS I, 1996, : 45 - 49
  • [33] P53 IN HUMAN PAPILLOMAVIRUS-ASSOCIATED ANOGENITAL CANCERS
    COOPER, K
    JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (04) : 393 - 393
  • [34] HUMAN PAPILLOMAVIRUS (HPV) AND P53 EXPRESSION IN CERVICAL DYSPLASIAS
    ROSE, J
    ISACSON, C
    ROBINSON, RA
    LABORATORY INVESTIGATION, 1994, 70 (01) : A95 - A95
  • [35] Human papillomavirus and p53 oncoprotein in verrucous carcinoma of the larynx
    LopezAmado, M
    GarciaCaballero, T
    LozanoRamirez, A
    LabellaCaballero, T
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1996, 110 (08): : 742 - 747
  • [36] Degradation of p53 by natural variants of the E6 protein of human papillomavirus type 16
    Yi, Ja Woon
    Jang, Mi
    Kim, Sung Jin
    Kim, Sung Soon
    Rhee, Jee Eun
    ONCOLOGY REPORTS, 2013, 29 (04) : 1617 - 1622
  • [37] Ubiquitin proteasomal pathway mediated degradation of p53 in melanoma
    Anwar, Adil
    Norris, David A.
    Fujita, Mayumi
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2011, 508 (02) : 198 - 203
  • [38] Characterization of sequence elements involved in p53 stability regulation reveals cell type dependence for p53 degradation
    Hengstermann, A
    Whitaker, NJ
    Zimmer, D
    Zentgraf, H
    Scheffner, M
    ONCOGENE, 1998, 17 (22) : 2933 - 2941
  • [39] Characterization of sequence elements involved in p53 stability regulation reveals cell type dependence for p53 degradation
    Arnd Hengstermann
    Noel J Whitaker
    Dagmar Zimmer
    Hanswalter Zentgraf
    Martin Scheffner
    Oncogene, 1998, 17 : 2933 - 2941
  • [40] Ubiquitin proteasomal pathway mediated degradation of p53 in melanoma
    Anwar, A.
    Shellman, Y. G.
    Norris, D. A.
    Fujita, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S21 - S21